Cosmetic firms getting nailed for chemical in varnish

News
Article

Nail polish makers Estee lauder and Procter & Gamble reformulate nail polishes--take DBP pthalate out amid health concerns

Recent Videos
Related Content
FDA Roundup: Hemophilia B Therapy, Stelara Biosimilar Approval

FDA Roundup: Hemophilia B Therapy, Stelara Biosimilar Approval

Killian Meara
October 11th 2024
Article

Check out important updates from the FDA for the week of October 7.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

Drug Topics staff
August 6th 2020
Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA Approves Imuldosa, Biosimilar to Stelara

FDA Approves Imuldosa, Biosimilar to Stelara

Lauren Massaro
October 11th 2024
Article

The approval is supported by results from phase 3 multi-regional clinical trials conducted in patients with plaque psoriasis.

FDA Accepts Bayer’s NDA for Elinzanetant to Treat Menopause Symptoms

FDA Accepts Bayer’s NDA for Elinzanetant to Treat Menopause Symptoms

Lauren Massaro
October 10th 2024
Article

The therapy’s Prescription Drug User Fee Act date has been set for July 26, 2025.

FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation

FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation

Killian Meara
October 4th 2024
Article

Check out important updates from the FDA for the week of September 30.

FDA Roundup: Agency Highlights from September 2024

FDA Roundup: Agency Highlights from September 2024

Killian Meara
September 27th 2024
Article

Check out these important FDA updates from the month of September 2024.

© 2024 MJH Life Sciences

All rights reserved.